18&19 - Cardiorespiratory Medicine Flashcards
Five smoking risks to the mother?
- Maternal DVT
- Pre-eclampsia
- Pre-term birth
Premature membrane rupture - Ectopic/Praevia
- Miscarriage
What are three methods of smoking cessation?
- NHS Stop Smoking
- Pharmaceuticals (NRT)
- E-Cigarettes
Smoking Cessation - Pharmaceuticals
Smoking cessation
1. Nicotine replacement Transdermal Lozenge Gum Inhaled Nasal
- Bupropion hydrochloride (150-300mg)
Or
Varenicline (500mcg-1mg) Attenuates withdrawal symptoms
- Clonidine (0.1-0.4mg) and nortriptyline (25-100mg)
Smoking cessation follow-up
Smoking cessation follow-up
- 2/52 of NRT
- 4/52 of Bupropion (antidepressant)/Vareniclone
3. Adherence CO level ADRs Withdrawal How’s it going?
E cigarettes
- Evidence
- ADRs
- Relative danger
E-cigarettes
- Growing evidence
- No CO
No Tar - Less harmful
Than liquid
Than vapour
Asthma reversibility test?
- Spirometry
- Salbutamol (2x200mgc)
Large volume spacer - 20-30 minutes
- Repeat spirometry
FEV1/FVC
What are different SABA inhalers?
Salbutamol
- MDI
Ventolin 100mcg
Salamol 100mcg
Airomir 100mcg - DPI
Ventolin 200mg
Terbutaline
Bricanyl 500mcg
What are different ICS inhalers?
ICS
Belclometasone
Clenil modulite 50mcg
QVAR 50 Autohaler 50mcg
Fluticasone
Flixotide propionate 50mcg
ICS/LABA
- Seretide 250/25
Fluticasone with salmeterol - Symbicort 200/10
Budesonide with formoterol - Fostair (100/6)
Beclometasone with formoterol
LABA Inhalers
- Salmeterol
Serevent 25mcg
Neovent 25mcg - Formoterol
Formoterol Easyhaler 12mcg
LAMA Inhaler
LAMA
- Spiriva
(Tiotropium) - Incruse
(Umeclinidium)
HFPEF
- Chronic Mx
Chronic HFPEF Mx
Conservative
- Diet + exercise
- Smoking and alcohol
Medical
- BP, DM, Lipids
- ACEi/ARB
- Ramipril
- Lorsartan - Furosemide/bumetanide
- Spironolactone/metolazone - BBlocker
- Bisoprlol
- Metoprolol
- Carvedilol
HFPEF
- Acute Mx
Acute HFPEF Mx
- Dieuretic
- Furosemide/bumetanide
- Spironolactone - Oxygen
- ACEi/ARB
- Nesiritide
Hypertensive emergency
5. IV GTN/nitroprusside
AF
- Beta blocker/CCB/Digoxin
- Anticoagulate
- ?Amiodarone
COPD
- GOLD Stages
Global initiative for chronic Obstructive Lung Disease
1 Early
- FEV-1: > 80%
- SoB walking fast
2 Moderate
- FEV-1: 50-79%
- SoB on level ground
3 Severe
- FEV-1: 30-49%
- SoB to leave house
4 Very severe
- FEV-1: <30%
- SoB at rest
COPD
- GOLD Groups
GOLD Groups
Group A
- Low risk
- Fewer symptoms
Group B
- Low risk
- More symptoms
Group C
- High risk
- Fewer symptoms
Group D
- High risk
- More symptoms